The legacy of Viagra, and its parent company copyright, presents a challenging case study for investors. At first a blockbuster drug, yielding billions in sales , its patent expiration created a deluge of generic competition , significantly eroding its market share . While specific pharmaceutical companies may try to capitalize on similar condition